R. Baldwin

The discovery of LY293111, a novel, potent and orally active leukotriene B4 receptor antagonist of the biphenylphenol class.

W. Jackson, M. Sofia, S. Silbaugh, 1997, Advances in experimental medicine and biology.

Biphenylyl-substituted xanthones: highly potent leukotriene B4 receptor antagonists.

M. Sofia, S. Silbaugh, J. S. Sawyer, 1993, Journal of Medicinal Chemistry.

Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonists.

J. S. Sawyer, J. Fleisch, J S Sawyer, 1992, Journal of medicinal chemistry.

Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.

W. Jackson, J. S. Sawyer, P. Floreancig, 1995, Journal of medicinal chemistry.

Initial state versus transition state solvation effects on the kinetics of oxidation of nickel(II) dioxocyclam by peroxodisulfate

R. Haines, R. Baldwin, 2002 .